2.69
2.69 (0%)
As of Feb 14, 2025
Mei Pharma, Inc. [MEIP]
Source:
Company Overview
MEI Pharma, Inc. is a pharmaceutical company that has been developing novel and differentiated cancer therapies. We built our pipeline by acquiring promising cancer agents and creating value in programs through clinical development, strategic partnerships, and out-licensing or commercialization, as appropriate.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | 858-369-7100 |
| Industry | manufacturing |
| CEO | Justin J. File |
| Website | www.meipharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $-3.5 |
| Net Income | $-2.7 |
| Net Cash | $20 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -8.1% |
| Profit as % of Stockholder Equity | -12.1% |
Management Effectiveness
| Return on Equity | -12.1% |
| Return on Assets | -11% |
| Turnover Ratio | |
| EBITA | $-3.5 |
Balance Sheet and Cash Flow Measures
| Total Assets | $24.4 |
| Total Liabilities | $2.3 |
| Operating Cash Flow | $-15.1 |
| Investing Cash Flow | $35.2 |
| Financing Cash Flow | $0 |
